Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113182897 | 11318289 | 7 | F | 20150526 | 20160721 | 20150728 | 20160725 | EXP | PHHY2015AU073991 | NOVARTIS | 87.42 | YR | M | Y | 0.00000 | 20160725 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113182897 | 11318289 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 10 MG, UNK | 346714 | 21008 | 10 | MG | |||||||
| 113182897 | 11318289 | 2 | C | PANADOL | ACETAMINOPHEN | 1 | Unknown | UNK | 0 | ||||||||||
| 113182897 | 11318289 | 3 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113182897 | 11318289 | 1 | Neuroendocrine tumour |
| 113182897 | 11318289 | 2 | Product used for unknown indication |
| 113182897 | 11318289 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113182897 | 11318289 | OT |
| 113182897 | 11318289 | HO |
| 113182897 | 11318289 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113182897 | 11318289 | Anaemia | |
| 113182897 | 11318289 | Chest pain | |
| 113182897 | 11318289 | Dizziness | |
| 113182897 | 11318289 | Dysphagia | |
| 113182897 | 11318289 | Feeling abnormal | |
| 113182897 | 11318289 | Full blood count decreased | |
| 113182897 | 11318289 | Malaise | |
| 113182897 | 11318289 | Myelodysplastic syndrome | |
| 113182897 | 11318289 | Second primary malignancy | |
| 113182897 | 11318289 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113182897 | 11318289 | 1 | 20141103 | 0 |